Sat.Jun 11, 2022 - Fri.Jun 17, 2022

FDA advisers recommend Pfizer, Moderna COVID-19 vaccines for youngest children

Bio Pharma Dive

Independent experts unanimously supported use of both shots in children aged 6 months to 5 years old, clearing the way for an FDA decision

US life expectancy continues historical decline.

World of DTC Marketing

According to a new report , life expectancy in the United States took another hit in 2021, furthering a dramatic decline from 2020 that was the largest since World War II. US life expectancy decreased from 78.86 years in 2019 to 76.99 years in 2020 and 76.60 years in 2021, a net loss of 2.26 years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Opioid use disorder: Flexible treatment at home proves effective

Scienmag

Did you know that more than 26,500 Canadians died from opioid intoxication between January 2016 and September 2021? Or that more than 350,000 people who used drugs containing opioids to relieve their pain did so problematically?

F.D.A. Approves Alopecia Drug That Restores Hair Growth in Many Patients

NY Times

The drug, made by Eli Lilly, is already used for rheumatoid arthritis, and could be followed by two more drugs from other companies. your-feed-science Alopecia Areata Eli Lilly and Company Food and Drug Administration Drugs (Pharmaceuticals) New England Journal of Medicine Hair

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Pharma under the microscope as FTC considers new ways to review acquisitions

Bio Pharma Dive

At a two-day meeting, experts argued drug divestitures may not be enough to prevent market concentration. Economists and regulators also appeared worried by the effect of buyouts on innovation

The importance in health insurance in retaining employees

World of DTC Marketing

Sixty percent of employees in a recent survey reported experiencing healthcare cost increases that outpaced inflation in the past three years, and 63 percent expect that trend to continue, signaling potential cost challenges in the future.

More Trending

Moderna Plans Trial Testing COVID-19 Vaccine in Youngest Babies

BioSpace

Moderna's study, dubbed BabyCove, is expected to begin recruiting in September and will include up to 700 babies three to six months of age

Roche Alzheimer's study fails in another setback to a long-tested hypothesis

Bio Pharma Dive

The failure is an upset not only to Roche, but also a blow to the wider Alzheimer’s research field, which has for years kept focus on a protein called beta amyloid

Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial

Pharma Phorum

The litany of failed trials of amyloid-targeting drugs for Alzheimer’s disease has added another verse, as Roche concedes that its crenezumab candidate was unable to slow cognitive decline in patients with an inherited form of the disease.

Accuracy of diagnostic mammograms may vary across racial and ethnic groups

Scienmag

Bottom Line: The accuracy of diagnostic mammograms differed across racial and ethnic groups, with variation in several measures of diagnostic performance.

An Innovative & Creative Problem Solver Approach to Selling in the Medical Device Space

Speaker: Steve Goldstein, Sales Leader

Currently in sales or involved in a business that depends on strong sales results? Join Steve Goldstein, Sales Success Coach, Motivational Speaker and Medical Device Sales Leader from Gold Selling LLC. You will absorb critical strategies to become a trusted partner in greater sales success.

Meet the Scientific Review Officer: Leaders of Peer Review

BioSpace

Peer review is integral to the scientific process, and one group plays a bigger role than you might think: Scientific Review Officers

93

Vertex, CRISPR strengthen case for pioneering gene-editing treatment

Bio Pharma Dive

Positive data from 75 patients with either sickle cell disease or beta thalassemia keep the companies’ therapy on track to become the first CRISPR-based treatment submitted to drug regulators, possibly by the end of the year

The top 5 barriers to type 2 diabetes patient recruitment, and how to overcome them

Clairnes

The post The top 5 barriers to type 2 diabetes patient recruitment, and how to overcome them appeared first on Clinical Trial Recruitment & Management Services. Blog clinical trial patient recruitment global patient recruitment type 2 diabetes patient recruitment

Rethinking the rabies vaccine

Scienmag

LA JOLLA—Rabies virus kills a shocking 59,000 people each year, many of them children. Some victims, especially kids, don’t realize they’ve been exposed until it is too late.

Mandatory COVID Vaccination Policy Template

The federal government is developing a rule requiring employers with more than 100 employees ensure their workers are vaccinated or produce a negative COVID test weekly before entering the workplace. So, what can your organization do to prepare? Get Paycor’s COVID Vaccination Policy Template to help communicate important details to your employees.

Genomics England will move HQ to Canary Wharf’s new biocluster

Pharma Phorum

Canary Wharf’s bid to become a new hub for the life sciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development.

With biotech in retreat, Third Rock raises $1B for life sciences investing

Bio Pharma Dive

The fund, Third Rock’s sixth, comes amid a significant downturn in the biotech stock market, which has raised questions about the viability of young drug startups

Pandemic highlights need for supply chain visibility, partnerships

Outsourcing Pharma

During BIO International, US leaders shared lessons learned from COVID-19, and how government and industry are collaborating to avoid future supply chain crises. Markets & Regulations

Priority Fields in Science and Technology Award

Scienmag

Marmara University graduate student Ya?mur mur Dalbudak was awarded a graduate fellowship program with her dissertation titled “Design and Synthesis of Conductive Hydrogels by Means of Deep Learning” while Marmara University doctoral student Halime YAKI?IK

Six months after authorization, what do we know about Paxlovid?

Pharma Phorum

It has now been over six months since the FDA authorized Paxlovid in December 2021 “for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS-CoV-2 viral testing who are also at high risk for progression to severe COVID-19.” .

HR 87

What Biotech and Pharma need to consider about decentralized trials

Bio Pharma Dive

The pandemic motivated sponsors to reimagine decentralized trials and realize the benefits these models deliver

Trials 254

Pfizer Vaccine Effective in Children Under 5, the F.D.A. Says

NY Times

Outside experts will make their recommendations this week on how the agency should rule on applications from Pfizer and Moderna to vaccinate the nation’s youngest children.

Training virtually can reduce psychosocial stress and anxiety

Scienmag

Previous research has described how virtual training produces acute cognitive and neural benefits. Building on those results, a new study suggests that a similar virtual training can also reduce psychosocial stress and anxiety.

Data-Led Digital KOL Engagement

Pharma Phorum

When creating engagement plans for individual Digital Key Opinion Leaders (DOLs), it’s best to look at a range of data-led metrics about each DOL to fine tune the engagement and maximise benefit for all parties.

Pfizer study results show Paxlovid benefit less clear in lower-risk patients

Bio Pharma Dive

A closely watched study missed its goal, failing to prove the antiviral pill’s benefit in a broader population than the high-risk individuals for which it’s currently cleared

217
217

Report: Merck Looks into Possible Buyout of Seagen

BioSpace

Pharmaceutical giant Merck is exploring a possible purchase of biotech company Seagen, according to The Wall Street Journal

83

Gaia space telescope rocks the science of asteroids

Scienmag

The European Gaia space mission has produced an unprecedented amount of new, improved, and detailed data for almost two billion objects in the Milky Way galaxy and the surrounding cosmos.

83

MorphoSys slims down, narrowing its focus to cancer

Pharma Phorum

MorphoSys seemingly inexorable shift into an oncology pure-play has continued with an out-licensing deal for two programmes in the kidney disease and immunology categories to China’s HIBio.

Amylyx's ALS drug gets approved in Canada

Bio Pharma Dive

The Massachusetts-based biotech is awaiting a decision in the U.S., where the FDA recently extended its review after agency advisers narrowly voted against the treatment

Drugs 219

‘Networking and relationship building key to finding answers to CGT challenges’

BioPharma Reporter

Measuring potency for gene and cell therapies is not so clear-cut, and some companies have hit roadblocks in their submissions to regulatory agencies as a result. Markets & Regulations

Gene 83

ACMG releases update to secondary findings gene list; SF v3.1 adds five genes, including one with variant linked to heart failure in underrepresented populations

Scienmag

The American College of Medical Genetics and Genomics (ACMG) has released an update to the recommended minimum gene list for the reporting of secondary findings (SF).

Gene 83

2nd NSCLC Drug Development Summit

Pharma Phorum

The 2nd NSCLC Drug Development Summit returns for its second year to unite biopharma and academic leaders during an exciting era of personalized medicine.

FDA approves Lilly, Incyte drug for alopecia, but includes safety warning

Bio Pharma Dive

The partners’ JAK inhibitor Olumiant is the first systemic treatment for an autoimmune disease that causes hair loss. But known risks of heart attacks and cancer could complicate its launch

BIO International: US CDMO looks to plug critical cell therapy manufacturing capacity shortage

BioPharma Reporter

The BIO International Convention in San Diego this week heard the US-based Center for Breakthrough Medicines (CBM) is to speed up plans to build what it calls the largest cell therapy manufacturing operation worldwide. Markets & Regulations

New research to help address blood shortages in Ireland

Scienmag

Friday, 17 June 2022: A study by RCSI University of Medicine and Health Sciences has identified barriers and motivators to blood donation for people from ethnic minority groups in Ireland.